162 related articles for article (PubMed ID: 26537425)
1. Effect of introducing aib in a designed helical inhibitor of hdm2-p53 interaction: A molecular dynamics study.
Chattopadhyay S; Ajani H; Basu G
Biopolymers; 2016 Jan; 106(1):51-61. PubMed ID: 26537425
[TBL] [Abstract][Full Text] [Related]
2. Aib-based peptide backbone as scaffolds for helical peptide mimics.
Banerjee R; Basu G; Chène P; Roy S
J Pept Res; 2002 Aug; 60(2):88-94. PubMed ID: 12102721
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2.
Grässlin A; Amoreira C; Baldridge KK; Robinson JA
Chembiochem; 2009 May; 10(8):1360-8. PubMed ID: 19408261
[TBL] [Abstract][Full Text] [Related]
4. Helical beta-peptide inhibitors of the p53-hDM2 interaction.
Kritzer JA; Lear JD; Hodsdon ME; Schepartz A
J Am Chem Soc; 2004 Aug; 126(31):9468-9. PubMed ID: 15291512
[TBL] [Abstract][Full Text] [Related]
5. Effect of linker on the binding free energy of stapled p53/HDM2 complex.
Im H; Ham S
PLoS One; 2020; 15(4):e0232613. PubMed ID: 32353067
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
Niu RJ; Zheng QC; Zhang JL; Zhang HX
J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction.
Fasan R; Dias RL; Moehle K; Zerbe O; Obrecht D; Mittl PR; Grütter MG; Robinson JA
Chembiochem; 2006 Mar; 7(3):515-26. PubMed ID: 16511824
[TBL] [Abstract][Full Text] [Related]
8. Conformational manifold of alpha-aminoisobutyric acid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy, electronic circular dichroism spectroscopy, and molecular dynamics simulations.
Schweitzer-Stenner R; Gonzales W; Bourne GT; Feng JA; Marshall GR
J Am Chem Soc; 2007 Oct; 129(43):13095-109. PubMed ID: 17918837
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the hdm2-p53 interaction.
Böttger A; Böttger V; Garcia-Echeverria C; Chène P; Hochkeppel HK; Sampson W; Ang K; Howard SF; Picksley SM; Lane DP
J Mol Biol; 1997 Jun; 269(5):744-56. PubMed ID: 9223638
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100.
Dastidar SG; Lane DP; Verma CS
BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S6. PubMed ID: 19958516
[TBL] [Abstract][Full Text] [Related]
11. Helical stability of de novo designed alpha-aminoisobutyric acid-rich peptides at high temperatures.
Augspurger JD; Bindra VA; Scheraga HA; Kuki A
Biochemistry; 1995 Feb; 34(8):2566-76. PubMed ID: 7873537
[TBL] [Abstract][Full Text] [Related]
12. Conformational preferences of a short Aib/Ala-based water-soluble peptide as a function of temperature.
Banerjee R; Chattopadhyay S; Basu G
Proteins; 2009 Jul; 76(1):184-200. PubMed ID: 19137603
[TBL] [Abstract][Full Text] [Related]
13. Aib residues in peptaibiotics and synthetic sequences: analysis of nonhelical conformations.
Aravinda S; Shamala N; Balaram P
Chem Biodivers; 2008 Jul; 5(7):1238-62. PubMed ID: 18649312
[TBL] [Abstract][Full Text] [Related]
14. Direct observations of conformational distributions of intrinsically disordered p53 peptides using UV Raman and explicit solvent simulations.
Xiong K; Zwier MC; Myshakina NS; Burger VM; Asher SA; Chong LT
J Phys Chem A; 2011 Sep; 115(34):9520-7. PubMed ID: 21528875
[TBL] [Abstract][Full Text] [Related]
15. Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction.
Cummings MD; Schubert C; Parks DJ; Calvo RR; LaFrance LV; Lattanze J; Milkiewicz KL; Lu T
Chem Biol Drug Des; 2006 Mar; 67(3):201-5. PubMed ID: 16611213
[TBL] [Abstract][Full Text] [Related]
16. Enhanced protein thermostability by Ala-->Aib replacement.
De Filippis V; De Antoni F; Frigo M; Polverino de Laureto P; Fontana A
Biochemistry; 1998 Feb; 37(6):1686-96. PubMed ID: 9484240
[TBL] [Abstract][Full Text] [Related]
17. Probing the structural requirements of peptoids that inhibit HDM2-p53 interactions.
Hara T; Durell SR; Myers MC; Appella DH
J Am Chem Soc; 2006 Feb; 128(6):1995-2004. PubMed ID: 16464101
[TBL] [Abstract][Full Text] [Related]
18. Miniature protein inhibitors of the p53-hDM2 interaction.
Kritzer JA; Zutshi R; Cheah M; Ran FA; Webman R; Wongjirad TM; Schepartz A
Chembiochem; 2006 Jan; 7(1):29-31. PubMed ID: 16397877
[No Abstract] [Full Text] [Related]
19. Deciphering the Multi-state Conformational Equilibrium of HDM2 in the Regulation of p53 Binding: Perspectives from Molecular Dynamics Simulation and NMR Analysis.
Watanabe K; Zhao Q; Iwatsuki R; Fukui R; Ren W; Sugita Y; Nishida N
J Am Chem Soc; 2024 Apr; 146(14):9790-9800. PubMed ID: 38549219
[TBL] [Abstract][Full Text] [Related]
20. Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide.
Zwier MC; Pratt AJ; Adelman JL; Kaus JW; Zuckerman DM; Chong LT
J Phys Chem Lett; 2016 Sep; 7(17):3440-5. PubMed ID: 27532687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
